These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 17627689

  • 1. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model.
    Aytan H, Caliskan AC, Demirturk F, Aytan P, Koseoglu DR.
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):321-5. PubMed ID: 17627689
    [Abstract] [Full Text] [Related]

  • 2. Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model.
    Demirturk F, Aytan H, Caliskan AC, Aytan P, Koseoglu DR.
    J Soc Gynecol Investig; 2006 Jan; 13(1):58-62. PubMed ID: 16378914
    [Abstract] [Full Text] [Related]

  • 3. Regression of endometrial explants in a rat model of endometriosis treated with melatonin.
    Güney M, Oral B, Karahan N, Mungan T.
    Fertil Steril; 2008 Apr; 89(4):934-42. PubMed ID: 17582405
    [Abstract] [Full Text] [Related]

  • 4. The effect of rosiglitazone in the prevention of intra-abdominal adhesion formation in a rat uterine horn model.
    Demirturk F, Aytan H, Caliskan A, Aytan P, Yener T, Koseoglu D, Yenisehirli A.
    Hum Reprod; 2006 Nov; 21(11):3008-13. PubMed ID: 16997937
    [Abstract] [Full Text] [Related]

  • 5. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
    Jeon EJ, Lee SK, Park YS, Kim DH, Yum JH, Park CS.
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J, Jin N, Wang G, Zhang F, Mao J, Wang X.
    Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
    [Abstract] [Full Text] [Related]

  • 7. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
    Sánchez-Hidalgo M, Martín AR, Villegas I, Alarcón De La Lastra C.
    Biochem Pharmacol; 2005 Jun 15; 69(12):1733-44. PubMed ID: 15876425
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of caffeic acid phenethyl ester on the regression of endometrial explants in an experimental rat model.
    Güney M, Nasir S, Oral B, Karahan N, Mungan T.
    Reprod Sci; 2007 Apr 15; 14(3):270-9. PubMed ID: 17636241
    [Abstract] [Full Text] [Related]

  • 10. PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study.
    Lebovic DI, Mwenda JM, Chai DC, Mueller MD, Santi A, Fisseha S, D'Hooghe T.
    Fertil Steril; 2007 Oct 15; 88(4 Suppl):1108-19. PubMed ID: 17498714
    [Abstract] [Full Text] [Related]

  • 11. Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats.
    Silva-Junior Gde O, Torres Tda S, Mendonca Lde S, Mandarim-de-Lacerda CA.
    Exp Toxicol Pathol; 2011 Jan 15; 63(1-2):1-7. PubMed ID: 19775877
    [Abstract] [Full Text] [Related]

  • 12. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS, Liu WJ, Chen L, Ou XM, Wang T, Feng YL, Zhang SF, Xu D, Chen YJ, Wen FQ.
    Toxicology; 2009 Jun 16; 260(1-3):112-9. PubMed ID: 19464576
    [Abstract] [Full Text] [Related]

  • 13. Regression of endometrial autografts in a rat model of endometriosis treated with etanercept.
    Islimye M, Kilic S, Zulfikaroglu E, Topcu O, Zergeroglu S, Batioglu S.
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov 16; 159(1):184-9. PubMed ID: 21741153
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis.
    Lebovic DI, Kir M, Casey CL.
    Fertil Steril; 2004 Oct 16; 82 Suppl 3():1008-13. PubMed ID: 15474065
    [Abstract] [Full Text] [Related]

  • 15. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats.
    Inan M, Basaran U, Dokmeci D, Kanter M, Yalcin O, Aydogdu N, Turan N.
    Clin Exp Pharmacol Physiol; 2007 Oct 16; 34(5-6):457-61. PubMed ID: 17439415
    [Abstract] [Full Text] [Related]

  • 16. Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction.
    Efrati S, Berman S, Chachashvili A, Cohen N, Siman-Tov Y, Averbukh Z, Weissgarten J.
    Nephrology (Carlton); 2009 Apr 16; 14(2):189-97. PubMed ID: 19143945
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.
    Allahtavakoli M, Shabanzadeh A, Roohbakhsh A, Pourshanazari A.
    Basic Clin Pharmacol Toxicol; 2007 Nov 16; 101(5):309-14. PubMed ID: 17910613
    [Abstract] [Full Text] [Related]

  • 18. Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis.
    Celiński K, Madro A, Prozorow-Król B, Korolczuk A, Cichoz-Lach H, Słomka M, Korobowicz E.
    Med Sci Monit; 2009 Jan 16; 15(1):BR21-9. PubMed ID: 19114961
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells.
    Zhang CH, Wen ZQ, Li JF, Li CZ, Shi M, Yang GW, Lan SM, Zhu Y, Wang F, Zhang YJ, Wang YY, Zhang H.
    Chin Med J (Engl); 2008 Jan 20; 121(2):166-71. PubMed ID: 18272045
    [Abstract] [Full Text] [Related]

  • 20. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone.
    Larsen PJ, Lykkegaard K, Larsen LK, Fleckner J, Sauerberg P, Wassermann K, Wulff EM.
    Eur J Pharmacol; 2008 Oct 31; 596(1-3):173-9. PubMed ID: 18761337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.